Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Operating Expenses (2018 - 2025)

Dna X (SONM) has disclosed Operating Expenses for 8 consecutive years, with $5.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 12.29% year-over-year to $5.8 million, compared with a TTM value of $43.0 million through Sep 2025, up 53.52%, and an annual FY2024 reading of $43.6 million, up 131.56% over the prior year.
  • Operating Expenses was $5.8 million for Q3 2025 at Dna X, down from $7.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $21.9 million in Q4 2024 and bottomed at $3.7 million in Q2 2023.
  • Average Operating Expenses over 5 years is $8.1 million, with a median of $7.1 million recorded in 2022.
  • The sharpest move saw Operating Expenses tumbled 58.06% in 2022, then skyrocketed 243.86% in 2024.
  • Year by year, Operating Expenses stood at $11.3 million in 2021, then crashed by 55.66% to $5.0 million in 2022, then grew by 27.73% to $6.4 million in 2023, then surged by 243.86% to $21.9 million in 2024, then crashed by 73.56% to $5.8 million in 2025.
  • Business Quant data shows Operating Expenses for SONM at $5.8 million in Q3 2025, $7.6 million in Q2 2025, and $7.7 million in Q1 2025.